Q4 2024 Earnings Call Transcript March 4, 2025 Y-mAbs Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Doug Gentilcore; DANYELZA Business Unit Head; Y-mAbs Therapeutics Inc Natalie Tucker; Senior Vice President and Radiopharmaceutical Business Unit Head; Y-mAbs Therapeutics Inc Thank you, operator, and ...

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...

Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Macrophages are important components ...

In honor of International Women's Day on March 8, ISRAEL21c compiled a list of eight legendary Israeli women in the sciences.

BACKGROUND: Lymphedema is an incurable disease associated with lymphatic dysfunction that causes tissue swelling and fibrosis. We investigated whether lymphedema could be attenuated by interfering ...

Artificial intelligence is making waves across industries, but its impact is higher in some sectors than others. Medicine and other sciences stand to gain much from this technology, thanks to their ...

Discover top AI stocks poised for growth ahead of the Stargate AI project and its potential impact on the industry.

Strength of Value-Added Portfolio Results in Solid Top-Line Performance Company Reaffirms Fiscal 2025 Net Sales and Adjusted Diluted Earnings Per Share Expectations ...

Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and ...

The main objectives were to investigate the ability of the probiotic strain to attenuate and or reverse low-dose, long-term ...

A global elderly and aging population has significant impacts, not only in terms of individual health risk but in terms of ...